Última atualização: Agosto 17, 2026

terapia com células-tronco

Stem Cell Market Size To Reach $15.63 Billion By 2025 | CAGR: 9.2%

The global stem cell market is expected to reach USD 15.63billion by 2025, growing at a CAGR of 9.2%, according to a new report by Grand View Research, Inc.. Augmentation in research studies that aim at broadening the utility scope of associated products is anticipated to drive the market growth. These research projects have opened the possibility of implementation of several clinical applications of these cells, thereby impacting disease-modifying treatments.

Scientists are engaged in discovering novel methods to create human stem cells. This is to address the increasing demand for stem cell production for potential investigation in disease management. This factor is certainly expected to accelerate the development of regenerative medicine, thus driving industrial growth.

Além disso, cellular therapies are recognized as the next major advancements in transforming healthcare. Firms are expanding their cellular therapy portfolio, understanding the future potential of this arena in the treatment of Parkinson’s disease, tipo 1 diabetes, lesão medular, Doença de Alzheimer, e outros.

Em março 2016, Scientists at Michigan State University unveiled new kind of cells “induced XEN cells” from a cellular trash pile. This discovery is expected to drive advancements in regenerative medicine. Such discoveries are anticipated to bolster research and sales in this market over the forecast period.

 

Further key findings from the report suggest:

Células-tronco adultas

dominated the market and is expected to maintain its dominance. This can be attributed to the several factors such as lower rejection rates, long term renewal property, and no ethical concerns associated with their usage

Application wise regenerative medicine is estimated to hold the substantial share of the revenue

Presence of significant number pipeline projects for regenerative medicine is expected to fuel growth in the market

Além disso, exploding research projects have driven the need of harvesting techniques, thereby propelling progress of acquisition technology

Increased R&D activities and huge funds granted by funding bodies to advance cellular research in the U.S. have resulted into the large share of North America

Extensive research carried out in Singapore and Japan is anticipated to drive progress with lucrative avenues

Advanced Cell Technology Inc, Osiris Therapeutics Inc, Celgene Corporation, BIOTIME, INC., Cynata, and STEMCELL Technologies Inc., are some of the major companies operating in this market

A number of stem cells companies

are engaged in seeking investment from overseas organizations and also developing partnerships with the pharmaceutical organizations

Grand View Research has segmented the global stem cells market on the basis of product, application, tecnologia, terapia, and region:

Stem Cell Product Outlook (Revenue, USD Billion, 2014 – 2025)

Células-tronco adultas

Neuronal Stem Cells

Células-tronco hematopoiéticas

Células-tronco mesenquimais

Células-tronco do cordão umbilical

Others

Human Embryonic Stem Cells

Células-tronco pluripotentes induzidas

Very Small Embryonic Like Stem Cells

Stem Cell Application Outlook (Revenue, USD Billion, 2014 – 2025)

Medicina Regenerativa

Neurologia

Ortopedia

Oncologia

Hematologia

Cardiovascular and Myocardial Infraction

Lesões

Diabetes

Liver Disorder

Incontinence

Others

Descoberta e desenvolvimento de medicamentos

Stem Cell Technology Outlook (Revenue, USD Billion, 2014 – 2025)

Cell Acquisition

Bone Marrow Harvest

Umbilical Blood Cord

Aférese

Cell Production

Clonagem Terapêutica

In-vitro Fertilization

Cell Culture

Isolamento

Criopreservação

Expansion and Sub-Culture

Stem Cell Therapy Outlook (Revenue, USD Billion, 2014 – 2025)

Terapia com células-tronco autólogas

Terapia alogênica com células-tronco

 

To request this report, please contact Dr Eugene Zadorin

( [email protected] )

 

 

 

Revisão de caso científico

Revisão de Caso Científico

Você gostaria de entender se os programas clínicos atuais, desenvolvimentos de pesquisa recentes, ou abordagens emergentes podem ser relevante para sua situação individual?

Compartilhe sua dúvida com nossa equipe de pesquisa científica e receba informações focadas nas áreas de pesquisa atual que podem ser relevante para o seu caso.

  • Revisão das informações que você fornece
  • Informações relevantes sobre pesquisas e programas clínicos
  • Uma resposta clara focada na sua situação
O que acontece a seguir? Envie sua pergunta, receber uma revisão científica focada, e obter uma resposta clara sobre pesquisas e programas clínicos relevantes para sua situação.
Sua revisão científica será preparada por Dr.. Helen Melnik, Doutorado , quem tem mais de 25 anos de experiência em pesquisa com células-tronco e programas clínicos internacionais.

Sem obrigação. Sua pergunta será analisada confidencialmente.

Apenas informações educacionais e de pesquisa. Este serviço não constituem aconselhamento médico, diagnóstico, prescrição, ou um personalizado recomendação de tratamento.


NBSciência

organização de pesquisa contratada

WhatsApp